Ohio Administrative Code Search
Rule |
---|
Rule 3701:1-58-26 | Authorization for calibration, transmission, and reference sources.
...(A) Any person authorized by rule 3701:1-58-06 of the Administrative Code for medical use of radioactive material may receive, possess, and use any of the following radioactive material for check, calibration, transmission, and reference use: (1) Sealed sources, not exceeding 1.11 gigabecquerels (thirty millicuries) each, manufactured and distributed by a person licensed under rule 3701:1-46-44 o... |
Rule 3701:1-58-26 | Authorization for calibration, transmission, and reference sources.
...(A) Any person authorized by rule 3701:1-58-06 of the Administrative Code for medical use of radioactive material may receive, possess, and use any of the following radioactive material for check, calibration, transmission, and reference use: (1) Sealed sources, not exceeding 1.11 gigabecquerels (thirty millicuries) each, manufactured and distributed by a person licensed under rule 3701:1-46-44 o... |
Rule 3701:1-58-27 | Requirements for possession of sealed sources and brachytherapy sources.
...(A) A licensee in possession of any sealed source or brachytherapy source shall follow the radiation safety and handling instructions supplied by the manufacturer. (B) A licensee in possession of a sealed source shall: (1) Test the source for leakage before its first use unless the licensee has a certificate from the supplier indicating that the source was tested within six months before transfer to the licensee; a... |
Rule 3701:1-58-29 | Surveys of ambient radiation exposure rate.
...(A) In addition to the surveys required by Chapter 3701:1-38 of the Administrative Code, a licensee shall survey, with a radiation detection survey instrument at the end of each day of use, the following: (1) All areas where unsealed radioactive material requiring a written directive was prepared for use or administered. This includes all unsealed radiopharmaceuticals prepared for use or administered under rule 370... |
Rule 3701:1-58-30 | Release of individuals containing unsealed radioactive material or implants containing radioactive material.
...(A) A licensee may authorize the release from its control of any individual who has been administered unsealed radioactive material or implants containing radioactive material if the total effective dose equivalent to any other individual from exposure to the released individual is not likely to exceed five millisieverts (0.5 rem). (B) A licensee shall provide the released individual, or the individual's parent or g... |
Rule 3701:1-58-30 | Release of individuals containing unsealed radioactive material or implants containing radioactive material.
...(A) A licensee may authorize the release from its control of any individual who has been administered unsealed radioactive material or implants containing radioactive material if the total effective dose equivalent to any other individual from exposure to the released individual is not likely to exceed five millisieverts (0.5 rem). (B) A licensee shall provide the released individual, or the indi... |
Rule 3701:1-58-31 | Provision of mobile medical service.
...(A) A licensee providing mobile medical service shall: (1) Obtain a letter signed by the management of each client for which services are rendered that permits the use of radioactive material at the client's address and clearly delineates the authority and responsibility of the licensee and the client; (2) Check instruments used to measure the activity of unsealed radioactive material for proper function before med... |
Rule 3701:1-58-32 | Use of unsealed radioactive material for uptake, dilution, and excretion studies for which a written directive is not required.
...Except for quantities that require a written directive under paragraph (B) of rule 3701:1-58-15 of the Administrative Code, a licensee may use any unsealed radioactive material prepared for medical use for uptake, dilution, or excretion studies that is: (A) Obtained from: (1) A manufacturer or preparer licensed under rule 3701:1-46-43 of the Administrative Code or equivalent United States nuclear regulatory commiss... |
Rule 3701:1-58-33 | Training for uptake, dilution, and excretion studies.
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user of unsealed radioactive material for the uses authorized under rule 3701:1-58-32 of the Administrative Code to be a physician who: (A) Is certified by a medical specialty board whose certification process has been recognized by the director, United States nuclear regulatory commission, or an agreement s... |
Rule 3701:1-58-33 | Training for uptake, dilution, and excretion studies.
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user of unsealed radioactive material for the uses authorized under rule 3701:1-58-32 of the Administrative Code to be a physician who: (A) Is certified by a medical specialty board whose certification process has been recognized by the director, United States nuclear regulatory commission, or a... |
Rule 3701:1-58-34 | Use of unsealed radioactive material for imaging and localization studies for which a written directive is not required.
...Except for quantities that require a written directive under paragraph (B) of rule 3701:1-58-15 of the Administrative Code, a licensee may use any unsealed radioactive material prepared for medical use for imaging and localization studies that is: (A) Obtained from: (1) A manufacturer or preparer licensed under rule 3701:1-46-43 of the Administrative Code or equivalent United States nuclear regulatory commission or... |
Rule 3701:1-58-35 | Permissible molybdenum-99, strontium-82, and strontium-85 concentrations.
...(A) A licensee may not administer to humans a radiopharmaceutical that contains: (1) More than 0.15 kilobecquerel of molybdenum-99 per megabecquerel of technetium-99m (0.15 microcurie of molybdenum-99 per millicurie of technetium-99m); or (2) More than 0.02 kilobecquerel of strontium-82 per megabecquerel of rubidium-82 chloride injection (0.02 microcurie of strontium-82 per millicurie of rubidium-82 chloride); or m... |
Rule 3701:1-58-35 | Permissible molybdenum-99, strontium-82, and strontium-85 concentrations.
...(A) A licensee may not administer to humans a radiopharmaceutical that contains: (1) More than 0.15 kilobecquerel of molybdenum-99 per megabecquerel of technetium-99m (0.15 microcurie of molybdenum-99 per millicurie of technetium-99m); or (2) More than 0.02 kilobecquerel of strontium-82 per megabecquerel of rubidium-82 chloride injection (0.02 microcurie of strontium-82 per millicurie of rubidiu... |
Rule 3701:1-58-36 | Training for imaging and localization studies.
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user of unsealed radioactive material for the uses authorized in rule 3701:1-58-34 of the Administrative Code to be a physician who: (A) Is certified by a medical specialty board whose certification process has been recognized by the director, United States nuclear regulatory commission, or an agreement state... |
Rule 3701:1-58-36 | Training for imaging and localization studies.
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user of unsealed radioactive material for the uses authorized in rule 3701:1-58-34 of the Administrative Code to be a physician who: (A) Is certified by a medical specialty board whose certification process has been recognized by the director, United States nuclear regulatory commission, or an a... |
Rule 3701:1-58-37 | Use of unsealed radioactive material for which a written directive is required.
...A licensee may use any unsealed radioactive material prepared for medical use and for which a written directive is required that is: (A) Obtained from: (1) A manufacturer or preparer licensed under rule 3701:1-46-43 of the Administrative Code or equivalent United States nuclear regulatory commission or agreement state requirements; or (2) A PET radioactive drug producer licensed in accordance with paragraph (I) o... |
Rule 3701:1-58-37 | Use of unsealed radioactive material for which a written directive is required.
...A licensee may use any unsealed radioactive material identified in paragraph (B)(1)(b)(vi) of rule 3701:1-58-40 the Administrative Code prepared for medical use and for which a written directive is required that is: (A) Obtained from: (1) A manufacturer or preparer licensed under rule 3701:1-46-43 of the Administrative Code or equivalent United States nuclear regulatory commission or agreement state ... |
Rule 3701:1-58-38 | Safety instruction for unsealed radioactive material.
...In addition to the requirements of rule 3701:1-38-10 of the Administrative Code, (A) A licensee shall provide radiation safety instruction, initially and at least annually, to personnel caring for patients or human research subjects who cannot be released under rule 3701:1-58-30 of the Administrative Code. To satisfy this requirement, the instruction must be commensurate with the duties of the personnel and include:... |
Rule 3701:1-58-39 | Safety precautions for unsealed radioactive material.
...(A) For each patient or human research subject who cannot be released under rule 3701:1-58-30 of the Administrative Code, a licensee shall: (1) Quarter the patient or the human research subject either in: (a) A private room with a private sanitary facility; or (b) A room, with a private sanitary facility, with another individual who also has received therapy with unsealed radioactive material and who also cannot b... |
Rule 3701:1-58-40 | Training for use of unsealed radioactive material for which a written directive is required.
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user of unsealed radioactive material for the uses authorized under rule 3701:1-58-37 of the Administrative Code to be a physician who: (A) Is certified by a medical specialty board whose certification process has been recognized by the director, United States nuclear regulatory commission, or an agreement st... |
Rule 3701:1-58-40 | Training for use of unsealed radioactive material for which a written directive is required.
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user of unsealed radioactive material for the uses authorized under rule 3701:1-58-37 of the Administrative Code to be a physician who: (A) Is certified by a medical specialty board whose certification process has been recognized by the director, United States nuclear regulatory commission, or a... |
Rule 3701:1-58-40 | Training for use of unsealed radioactive material for which a written directive is required.
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user of unsealed radioactive material for the uses authorized under rule 3701:1-58-37 of the Administrative Code to be a physician who: (A) Is certified by a medical specialty board whose certification process has been recognized by the director, United States nuclear regulatory commission, or a... |
Rule 3701:1-58-41 | Training for the oral administration of sodium iodide iodine-131 requiring a written directive in quantities less than or equal to 1.22 gigabecquerels (thirty-three millicuries).
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user for the oral administration of sodium iodide iodine-131 requiring a written directive in quantities less than or equal to 1.22 gigabecquerels (thirty-three millicuries) to be a physician who: (A) Is certified by a medical specialty board whose certification process includes all of the requirements in par... |
Rule 3701:1-58-41 | Training for the oral administration of sodium iodide iodine-131 requiring a written directive in quantities less than or equal to 1.22 gigabecquerels (thirty-three millicuries).
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user for the oral administration of sodium iodide iodine-131 requiring a written directive in quantities less than or equal to 1.22 gigabecquerels (thirty-three millicuries) to be a physician who: (A) Is certified by a medical specialty board whose certification process includes all of the require... |
Rule 3701:1-58-42 | Training for the oral administration of sodium iodide iodine-131 requiring a written directive in quantities greater than 1.22 gigabecquerels (thirty-three millicuries).
...Except as provided in rule 3701:1-58-21 of the Administrative Code, the licensee shall require an authorized user for the oral administration of sodium iodide iodine-131 requiring a written directive in quantities greater than 1.22 gigabecquerels (thirty-three millicuries) to be a physician who: (A) Is certified by a medical specialty board whose certification process includes all of the requirements in paragraphs (... |